Insider · CIK 0001856371

Scanlan Sean F.

Reports to the SEC for 1 company · PONTE VEDRA, FL

sec.gov

Transactions

Companies

Filings

CIK

0001856371

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-09	TMCITREACE MEDICAL CONCEPTS, INC.F Tax Payment	Chief Innovation Officer	FTax Payment	−9,814 sh	—	—	679,863
2026-03-10	TMCITREACE MEDICAL CONCEPTS, INC.F Tax Payment	Chief Innovation Officer	FTax Payment	−1,396 sh	—	—	704,677
2026-03-08	TMCITREACE MEDICAL CONCEPTS, INC.F Tax Payment	Chief Innovation Officer	FTax Payment	−401 sh	—	—	706,073
2026-02-10	TMCITREACE MEDICAL CONCEPTS, INC.M Exercise/Conversion	Chief Innovation Officer	MExercise/Conversion	+16.9K sh	$1.05	+$17.7K	706,474
2026-02-10	TMCITREACE MEDICAL CONCEPTS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Innovation Officer	MExercise/Conversion	−16.9K sh	—	—	0
2026-01-22	TMCITREACE MEDICAL CONCEPTS, INC.A Award	Chief Innovation Officer	AAward	+263K sh	—	—	689,599
2026-01-21	TMCITREACE MEDICAL CONCEPTS, INC.M Exercise/Conversion	Chief Innovation Officer	MExercise/Conversion	+53.5K sh	$0.72	+$38.5K	427,099
2026-01-21	TMCITREACE MEDICAL CONCEPTS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Innovation Officer	MExercise/Conversion	+53.5K sh	—	—	0
2025-10-24	TMCITREACE MEDICAL CONCEPTS, INC.F Tax Payment	Chief Innovation Officer	FTax Payment	−208 sh	—	—	373,599
2025-08-09	TMCITREACE MEDICAL CONCEPTS, INC.F Tax Payment	Chief Innovation Officer	FTax Payment	−9,814 sh	—	—	373,807
2025-07-18	TMCITREACE MEDICAL CONCEPTS, INC.M Exercise/Conversion	Chief Innovation Officer	MExercise/Conversion	+33.4K sh	$0.72	+$24K	383,621
2025-07-18	TMCITREACE MEDICAL CONCEPTS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Innovation Officer	MExercise/Conversion	−33.4K sh	—	—	0
2025-03-17	TMCITREACE MEDICAL CONCEPTS, INC.M Exercise/Conversion	Chief Innovation Officer	MExercise/Conversion	+50K sh	$1.05	+$52.5K	414,081
2025-03-17	TMCITREACE MEDICAL CONCEPTS, INC.S Sale	Chief Innovation Officer	SSale	−50K sh	$7.97	−$398K	364,081
2025-03-17	TMCITREACE MEDICAL CONCEPTS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Innovation Officer	MExercise/Conversion	−50K sh	—	—	16,875
2025-03-10	TMCITREACE MEDICAL CONCEPTS, INC.F Tax Payment	Chief Innovation Officer	FTax Payment	−1,396 sh	—	—	364,081
2025-03-08	TMCITREACE MEDICAL CONCEPTS, INC.F Tax Payment	Chief Innovation Officer	FTax Payment	−401 sh	—	—	365,477
2025-01-22	TMCITREACE MEDICAL CONCEPTS, INC.A Award	Chief Innovation Officer	AAward	+141K sh	—	—	365,878
2025-01-10	TMCITREACE MEDICAL CONCEPTS, INC.F Tax Payment	Chief Innovation Officer	FTax Payment	−4,821 sh	—	—	225,253
2024-09-12	TMCITREACE MEDICAL CONCEPTS, INC.M Exercise/Conversion	Chief Innovation Officer	MExercise/Conversion	+33.8K sh	$0.10	+$3,280.5	250,074
2024-09-12	TMCITREACE MEDICAL CONCEPTS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Innovation Officer	MExercise/Conversion	−33.8K sh	—	—	0
2024-08-09	TMCITREACE MEDICAL CONCEPTS, INC.A Award	Chief Innovation Officer	AAward	+121K sh	—	—	216,324
2024-03-10	TMCITREACE MEDICAL CONCEPTS, INC.F Tax Payment	Chief Innovation Officer	FTax Payment	−1,396 sh	—	—	95,424
2024-03-08	TMCITREACE MEDICAL CONCEPTS, INC.F Tax Payment	Chief Innovation Officer	FTax Payment	−389 sh	—	—	96,820
2024-01-10	TMCITREACE MEDICAL CONCEPTS, INC.A Award	Chief Innovation Officer	AAward	+65K sh	—	—	97,209
2024-01-10	TMCITREACE MEDICAL CONCEPTS, INC. · Stock Option (Right to Buy)A Award	Chief Innovation Officer	AAward	+73.2K sh	—	—	73,200
2023-11-02	TMCITREACE MEDICAL CONCEPTS, INC.F Tax Payment	Chief Innovation Officer	FTax Payment	−211 sh	—	—	32,184
2023-05-16	TMCITREACE MEDICAL CONCEPTS, INC.M Exercise/Conversion	Chief Innovation Officer	MExercise/Conversion	+25K sh	$0.10	+$2,500	57,395
2023-05-16	TMCITREACE MEDICAL CONCEPTS, INC.S Sale	Chief Innovation Officer	SSale	−25K sh	$25.44	−$636K	32,395
2023-05-16	TMCITREACE MEDICAL CONCEPTS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Innovation Officer	MExercise/Conversion	−25K sh	—	—	33,750
2023-03-10	TMCITREACE MEDICAL CONCEPTS, INC.A Award	Chief Innovation Officer	AAward	+22.9K sh	—	—	32,395
2023-03-10	TMCITREACE MEDICAL CONCEPTS, INC. · Stock Option (Right to Buy)A Award	Chief Innovation Officer	AAward	−52K sh	—	—	51,950
2023-03-09	TMCITREACE MEDICAL CONCEPTS, INC.S Sale	Chief Innovation Officer	SSale	−505 sh	$24.41	−$12.3K	9,470
2023-02-15	TMCITREACE MEDICAL CONCEPTS, INC.M Exercise/Conversion	Chief Innovation Officer	MExercise/Conversion	+25K sh	$0.10	+$2,500	34,975
2023-02-15	TMCITREACE MEDICAL CONCEPTS, INC.S Sale	Chief Innovation Officer	SSale	−25K sh	$21.69	−$542K	9,975
2023-02-15	TMCITREACE MEDICAL CONCEPTS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Innovation Officer	MExercise/Conversion	−25K sh	$0.10	−$2,500	58,750
2023-01-12	TMCITREACE MEDICAL CONCEPTS, INC.M Exercise/Conversion	Chief Innovation Officer	MExercise/Conversion	+25K sh	$0.10	+$2,500	34,975
2023-01-12	TMCITREACE MEDICAL CONCEPTS, INC.S Sale	Chief Innovation Officer	SSale	−25K sh	$25.57	−$639K	9,975
2023-01-12	TMCITREACE MEDICAL CONCEPTS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Innovation Officer	MExercise/Conversion	−25K sh	$0.10	−$2,500	83,750
2022-11-14	TMCITREACE MEDICAL CONCEPTS, INC.M Exercise/Conversion	Chief Innovation Officer	MExercise/Conversion	+25K sh	$0.10	+$2,500	34,975
2022-11-14	TMCITREACE MEDICAL CONCEPTS, INC.S Sale	Chief Innovation Officer	SSale	−25K sh	$24.27	−$607K	9,975
2022-11-14	TMCITREACE MEDICAL CONCEPTS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Innovation Officer	MExercise/Conversion	−25K sh	$0.10	−$2,500	108,750
2022-10-24	TMCITREACE MEDICAL CONCEPTS, INC.A Award	Chief Innovation Officer	AAward	+3,400 sh	—	—	9,975
2022-10-24	TMCITREACE MEDICAL CONCEPTS, INC. · Stock Option (Right to Buy)A Award	Chief Innovation Officer	AAward	+23K sh	—	—	23,000
2022-03-08	TMCITREACE MEDICAL CONCEPTS, INC.A Award	Chief Innovation Officer	AAward	+6,575 sh	—	—	6,575
2022-03-08	TMCITREACE MEDICAL CONCEPTS, INC. · Stock Option (Right to Buy)A Award	Chief Innovation Officer	AAward	+50.7K sh	—	—	50,650
2022-03-02	TMCITREACE MEDICAL CONCEPTS, INC.M Exercise/Conversion	Chief Innovation Officer	MExercise/Conversion	+25K sh	$1.05	+$26.3K	25,000
2022-03-02	TMCITREACE MEDICAL CONCEPTS, INC.S Sale	Chief Innovation Officer	SSale	−25K sh	$20.82	−$521K	0
2022-03-02	TMCITREACE MEDICAL CONCEPTS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Innovation Officer	MExercise/Conversion	−25K sh	—	—	124,149
2022-02-09	TMCITREACE MEDICAL CONCEPTS, INC.M Exercise/Conversion	Chief Innovation Officer	MExercise/Conversion	+3,873 sh	$1.05	+$4,066.65	3,873

Recent filings

Accepted (ET)
Aug 124
Scanlan Sean F.0001193125-26-347275
SEC(opens sec.gov)
Mar 114
Scanlan Sean F.0001193125-26-102763
SEC(opens sec.gov)
Feb 114
Scanlan Sean F.0001193125-26-047313
SEC(opens sec.gov)
Jan 234
Scanlan Sean F.0001193125-26-021450
SEC(opens sec.gov)
Oct 284
Scanlan Sean F.0001193125-25-253801
SEC(opens sec.gov)
Aug 124
Scanlan Sean F.0000950170-25-107555
SEC(opens sec.gov)
Jul 224
Scanlan Sean F.0000950170-25-097601
SEC(opens sec.gov)
Mar 194
Scanlan Sean F.0000950170-25-042291
SEC(opens sec.gov)
Mar 114
Scanlan Sean F.0000950170-25-037572
SEC(opens sec.gov)
Jan 244
Scanlan Sean F.0000950170-25-008973
SEC(opens sec.gov)
Jan 144
Scanlan Sean F.0000950170-25-005580
SEC(opens sec.gov)
Sep 164
Scanlan Sean F.0000950170-24-106856
SEC(opens sec.gov)

Companies

TREACE MEDICAL CONCEPTS, INC.Chief Innovation OfficerTMCI

Address

C/O TREACE MEDICAL CONCEPTS, INC. 100 PALMETTO PARK PLACE

PONTE VEDRA, FL, 32081